1-6 of 6
Chiai Nagae
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AKATSUKI third interim analysis: Safety of emicizumab during and after immune tolerance induction implementation

Free
Keiji Nogami, Nobuaki Suzuki, Chiai Nagae, Azusa Nagao, Masahiko Ando, Yachiyo Kuwatsuka, Akiko Ioka, Yoichi Murakami, Tomomi Shimura, Tadashi Matsushita
Journal: Blood
Blood (2025) 146 (Supplement 1): 303.
https://doi.org/10.1182/blood-2025-303
Published: 2025
Journal Articles

Assessment of coagulation potential of concomitant factor VIII administration in patients with haemophilia a receiving emicizumab prophylaxis (CAGUYAMA Study): A multicenter, open-label, non-randomized clinical trial

Free
Masahiro Takeyama, Kenichi Ogiwara, Naoki Ozu, Kana Sasai, Masato Kasahara, Yasuko Furuichi, Toshio Takase, Iyou Nakagawa, Katsuyuki Fukutake, Akira Ishiguro, Kagehiro Amano, Eisuke Adachi, Kumiko Ono, Chiai Nagae, Atsuki Yamashita, Satoshi Higasa, Teruhisa Fujii, Masanori Matsumoto, Midori Shima, Keiji Nogami
Journal: Blood
Blood (2025) 146 (Supplement 1): 4847.
https://doi.org/10.1182/blood-2025-4847
Published: 2025
Journal Articles

Emicizumab and Immune Tolerance Induction in People with Hemophilia A and Factor VIII Inhibitors: 96-Week Interim Analysis of the AKATSUKI Study

Free
Azusa Nagao, Keiji Nogami, Nobuaki Suzuki, Chiai Nagae, Masahiko Ando, Yachiyo Kuwatsuka, Daisuke Nosaka, Yui Kyogoku, Tomomi Shimura, Tadashi Matsushita
Journal: Blood
Blood (2024) 144 (Supplement 1): 2588.
https://doi.org/10.1182/blood-2024-193535
Published: 2024
Journal Articles

TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors

Free
Keiji Nogami, Teruhisa Fujii, Akihiro Sawada, Azusa Nagao, Chiai Nagae, Masanori Nojima, Nobuaki Suzuki, Mika Kawano, Tomomi Shimura, Yoshimasa Sugao, Kagehiro Amano
Journal: Blood
Blood (2024) 144 (Supplement 1): 1211.
https://doi.org/10.1182/blood-2024-193537
Published: 2024
Journal Articles

Three-Year Interim Analysis Results of the AOZORA Study to Evaluate the Long-Term Safety and Joint Health in Children with Hemophilia A without Factor VIII Inhibitors Receiving Emicizumab

Free
Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Chiai Nagae, Azusa Nagao, Daisuke Nosaka, Yui Kyogoku, Hiroki Oki, Keisuke Iwasaki, Keiji Nogami
Journal: Blood
Blood (2023) 142 (Supplement 1): 3991.
https://doi.org/10.1182/blood-2023-173073
Published: 2023
Journal Articles

AKATSUKI 48-Week Interim Analysis: Emicizumab and Immune Tolerance Induction in People with Hemophilia A and Factor VIII Inhibitors

Free
Tadashi Matsushita, Nobuaki Suzuki, Chiai Nagae, Azusa Nagao, Masahiko Ando, Yachiyo Kuwatsuka, Daisuke Nosaka, Yui Kyogoku, Tomomi Shimura, Keiji Nogami
Journal: Blood
Blood (2023) 142 (Supplement 1): 2625.
https://doi.org/10.1182/blood-2023-173071
Published: 2023